Godavari Drugs Limited (BOM:530317)

Godavari Drugs Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	37.02	43.8	55.49	37.86	52.45	41.28
Depreciation & Amortization	25.24	24.48	24.48	19.44	16.96	12.23
Other Operating Activities	43.63	38.45	42.01	31.94	25.73	28.98
Change in Accounts Receivable	27	171	-14.88	-23.56	-104.58	-91.03
Change in Inventory	-160.27	-72.91	-7.95	-98.22	46.16	31.02
Change in Other Net Operating Assets	175.68	-92.85	85	164.72	75.57	-9.2
Operating Cash Flow	148.3	111.96	184.14	132.17	112.3	13.28
Operating Cash Flow Growth	6.56%	-39.20%	39.32%	17.70%	745.75%	-78.73%
Capital Expenditures	-221.27	-199.98	-132.01	-93.36	-52.45	-16.72
Sale of Property, Plant & Equipment	-	-	1.88	1.48	-	-
Other Investing Activities	5.67	4.86	-2.08	5.49	2.74	4.22
Investing Cash Flow	-215.6	-195.12	-132.22	-86.39	-49.71	-12.5
Long-Term Debt Issued	-	127.28	-	1.65	-	33.26
Total Debt Issued	100.71	127.28	-	1.65	-	33.26
Long-Term Debt Repaid	-	-	-7.8	-	-27.08	-
Net Debt Issued (Repaid)	100.71	127.28	-7.8	1.65	-27.08	33.26
Other Financing Activities	-40.26	-46.61	-48.74	-39.36	-29.13	-31.92
Financing Cash Flow	60.45	80.67	-56.54	-37.7	-56.21	1.34
Net Cash Flow	-6.85	-2.5	-4.62	8.08	6.38	2.12
Free Cash Flow	-72.97	-88.02	52.12	38.81	59.85	-3.44
Free Cash Flow Growth	-	-	34.30%	-35.15%	-	-
Free Cash Flow Margin	-6.88%	-7.71%	3.31%	2.43%	3.71%	-0.28%
Free Cash Flow Per Share	-9.70	-11.70	6.92	5.16	7.95	-0.46
Cash Interest Paid	41.3	47.32	49.15	39.27	28.49	33.08
Cash Income Tax Paid	-	11.55	10.17	12.27	12.27	11.88
Levered Free Cash Flow	-162.85	-72.71	-12.12	-336.51	67.61	-38.11
Unlevered Free Cash Flow	-137.04	-43.14	18.6	-311.97	85.42	-18.18
Change in Working Capital	42.41	5.24	62.17	42.94	17.15	-69.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.